Coverage
-
September 22, 2023
A Colorado federal judge denied a new trial bid by Novartis' generic-drug making arm Sandoz over a patent covering a drug to grow eyelashes after a jury awarded $39 million to Allergan, rejecting the argument that the court erred in applying Federal Circuit precedent.
6 other articles on this case.
View all »